| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 08/07/2008 | US20080188528 Modulators of C3a receptor and methods of use thereof |
| 08/07/2008 | US20080188491 Modulation of pathogenicity |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188385 Process for the preparation of polyalkenyl succinic anhydrides |
| 08/07/2008 | DE102007061631A1 Verfahren zur Herstellung von Mycophenolat-Mofetil Process for the preparation of mycophenolate mofetil |
| 08/06/2008 | EP1953152A1 Process for preparing quinazoline RHO-kinase inhibitors and intermediates thereof |
| 08/06/2008 | EP1951726A2 Method for the preparation of escitalopram |
| 08/06/2008 | EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 08/06/2008 | EP1951701A2 Ep2 receptor agonists |
| 08/06/2008 | EP1951663A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
| 08/06/2008 | EP1951217A2 Chemical compounds |
| 08/06/2008 | EP1838405B1 Method for producing phthalic anhydride that conforms to specifications |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | CN101238111A Cyclic ketal beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 08/06/2008 | CN101235023A Method for synthesizing spirodiclofen |
| 08/06/2008 | CN101235006A N-substituted aroylamino-N'-substituted phenoxyacetylthiourea derivatives, preparation and application thereof |
| 08/06/2008 | CN101234999A N-substituted formacyl glycyl hydrazine derivatives, preparation method and application thereof |
| 08/06/2008 | CN100408571C Andrographolide-trimaleate and its salt and their medicine composition |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/06/2008 | CN100408164C Titaniun-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride |
| 08/05/2008 | US7408077 Permanent surface modifiers |
| 08/05/2008 | US7408072 Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state |
| 08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2137529C Salt compositions and functional fluids using same |
| 07/31/2008 | WO2008091818A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | WO2008091368A1 Methods for producing and purifying phenolphthalein |
| 07/31/2008 | WO2008091011A1 Novel ester group-containing tetracarboxylic acid dianhydride, novel polyesterimide precursor derived therefrom, and polyesterimide |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090717A1 Adam inhibitor |
| 07/31/2008 | WO2008090640A1 Oxime compound, photosensitive composition, color filter, method for production of the color filter, and liquid crystal display element |
| 07/31/2008 | WO2008090046A1 Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 07/31/2008 | WO2008089556A1 A novel crystalline mycophenolate sodium polymorph and processes to manufacture same |
| 07/31/2008 | WO2008042896A3 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 07/31/2008 | WO2008036653A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/31/2008 | US20080182998 preparing a suspension of crystalline Form CG in toluene; heating said suspension at reflux; crystallizing the crystalline form; and recovering the crystalline Form M2 |
| 07/31/2008 | US20080182996 Method For Separating Maleic Anhydride From Mixtures Containing the Same by Means of Stripping |
| 07/31/2008 | US20080182944 Formaldehyde free binders |
| 07/31/2008 | US20080182878 benzothienyl containing amido-derivatives, antibacterial agent; quorum sensing regulated virulence factors; inhibiting biofilm formation; virulence gene expression blocking agent, disinfectants, antifouling coatings |
| 07/31/2008 | DE102007004961A1 Preparing a catalyst molded body, useful e.g. to prepare catalyst for gas phase partial oxidation of an organic compound, comprises molding a precursor mixture to a desired geometry, using graphite, and thermally treating the molded body |
| 07/31/2008 | CA2676252A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | CA2676208A1 Compound, a1 adrenergic receptor antagonist agent, and composition |
| 07/30/2008 | EP1950208A1 Process for producing 6,6-dimethyl-3-oxabicyclo[3.1.0]hexan-2-one |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1948643A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/30/2008 | EP1761514B1 Novel tetracyclic tetrahydrofuran derivatives |
| 07/30/2008 | EP1377564B1 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines |
| 07/30/2008 | CN101230054A Method for preparing alpha-acetyl-gamma-butyrolactone |
| 07/30/2008 | CN100406451C Process for preparing prostaglandin derivatives and starting materials for the same |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405318 reacting aldehyde oximes with cyclic alkylphosphonic anhydrides in the presence of an amine base, to form nitriles |
| 07/29/2008 | US7405311 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2323315C Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 07/29/2008 | CA2286822C Kodaistatins a, b, c and d, a process for their production and their use |
| 07/29/2008 | CA2205811C Multifunctional cyanate ester and epoxy blends |
| 07/24/2008 | WO2008089301A2 Gas phase reaction process for polyhydric compounds |
| 07/24/2008 | WO2008062468A3 Process for the preparation of optically pure indeno [5,4-b] furan derivatives |
| 07/24/2008 | WO2008020939A3 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 07/24/2008 | WO2007120528A3 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
| 07/24/2008 | US20080177096 Escitalopram with chiral purity greater than 99.8% obtained in more than 50% yield; without chiral chromatographic separation |
| 07/24/2008 | US20080177093 Use of an oxidopyrylium species as an intermediate in a chemical reaction; oxidopyrylium species is generated photochemically from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile |
| 07/24/2008 | US20080177091 Methods for producing and purifying phenolphthalein |
| 07/24/2008 | US20080177073 Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites |
| 07/24/2008 | US20080177020 Non-metallocene organometallic complexes and related methods and systems |
| 07/24/2008 | US20080176938 Modulation of pathogenicity |
| 07/24/2008 | US20080176903 Novel Compounds with Analgesic Effect |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
| 07/23/2008 | EP1945623A2 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
| 07/23/2008 | EP1945622A1 Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1667987B1 Process for the production of mycophenolate mofetil |
| 07/23/2008 | EP1575930B1 Novel retinol derivative and cosmetic composition comprising the same |
| 07/23/2008 | EP1420774B1 Preparation and diabetic use of gibberellins |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228154A Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 07/23/2008 | CN101228147A Novel rhodamine dyes |
| 07/23/2008 | CN101228146A Benzofuran derivatives with therapeutic activities |
| 07/23/2008 | CN101228133A Heteroaroyl-substituted serineamides |
| 07/23/2008 | CN100404521C Compound separated from petroleum ether extract of glycyrrhiza legume bacteria strain CCNWGX022 fermentation liquid |
| 07/23/2008 | CA2585601A1 A novel crystalline mycophenolate sodium polymorph and processes to manufacture same |
| 07/23/2008 | CA2574940A1 A novel crystalline mycophenolate sodium polymorph and processes to manufacture same |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |